CCL2 and neoplasm: Moreover, neddylation inhibition was proved to decrease macrophage tumor infiltration through chemotactic cytokine ligand 2 (CCL2) reduction, thus modulates the tumor microenvironment and could be a potent cancer therapy (Zhou et al., 2019; Meerang et al., 2020).